Menu ×


Animal Arthritis Treatment Market Segmentation by Treatment (Non-Steroidal Anti-Inflammatory Medications (NSAIDs), Opioids, Stem Cell Therapy, and Others); and by Distribution Channel (Online, and Offline) – Global Demand Analysis and Opportunity Outlook 2021-2029

  • Text Size:

Extensive insights into the Growth of Animal Arthritis Treatment Market amidst COVID-19

Before we witness the stabilization of economic growth in Europe and North America, Asia Pacific is estimated to bounce back progressively with countries such as China, India, South Korea and Japan witnessing more opportunities to recover from the losses sustained during COVID-19.

Being the biggest market in Eastern Europe, Russia is estimated to take the lowest hit, offering a sigh of relief to the businesses operating in the country. Whereas, GCC is estimated to observe low investments due to the sliding prices of crude oil.

We evaluate the strategies and commitment of the Giant Players in the market towards creating products and services that customers value and rely on.

In an attempt to control and eliminate the surge of coronavirus cases and meet the demand for required medical devices along with providing efficient medical services, there is a drastic shift of investments from authoritative bodies towards the healthcare sector. Where the aftermath of this pandemic may take years to be measured, Research Nester estimates notable expansion of e-health, gaming, and media and entertainment industries till the whole situation is contained and the plan of action for the recovery process is determined. There is an estimated probability of the growth in businesses going back a year if the condition is controlled in the next 2-3 months.                                                         Request Insights

Read More

Animal Arthritis Treatment Market Highlights 2020-2029

The animal arthritis treatment market is estimated to grow with a moderate CAGR during the forecast period, i.e., 2021-2029. The increasing incidences of arthritis in dogs, particularly osteoarthritis, is the major factor driving the growth of the canine arthritis treatment industry. Osteoarthritis affects as many as one in five dogs and is a common problem in older dogs and large breeds. According to the data collected from Veterinary Science Development, one in four of 77.2 million pet dogs in the United States are diagnosed with some form of arthritis.


The market is segmented based on treatment into non-steroidal anti-inflammatory medications (NSAIDS), opioids, stem cell therapy out of which, the NSAIDS segment is anticipated to grab the largest share by the end of 2021. The demand for NSAIDs in on a perpetual rise as it lowers the production of prostaglandins-associated with driving inflammation leading to arthritis. In terms of treatment, NSAIDs are continue to be the globally accepted mainstay of pharmaceutical treatment for canine arthritis, further shaping the canine arthritis treatment market. Research suggests that more than 60% of canines above the age of 7, suffer from degenerative joint diseases.  CLICK TO DOWNLOAD SAMPLE REPORT

On the basis of distribution channel, the offline segment in the global animal arthritis treatment market is projected to grow with a significant CAGR over the forecast period. The growth of the segment can be attributed to the fact that offline distribution channel serves to a larger customer base due to its presence. Veterinary pharmacies and veterinary clinics serve to large customers, hence contributes to a larger share of the market.

Animal Arthritis Treatment Market Regional Synopsis

Geographically, the market is segmented into North America, Latin America, Europe, Asia Pacific and the Middle East & Africa region. North America is expected to dominate the global canine arthritis treatment market and continue its dominance over the forecast period. This growth is attributable to the higher consumption from countries like the US. According to the American Pet Products Association, the number of pet and expenditure on their health is higher in the US. Thus, the region is accounting for the higher revenue in the global canine arthritis treatment market. However, Europe and the Asia Pacific are expected to grow with higher CAGR over the forecast period. The factors such as growing disposable income and raising awareness about the pet health are leading to conduct higher growth in both the regions.


The global animal arthritis treatment market is further classified on the basis of region as follows:

  • North America (U.S. & Canada) Market size, Y-O-Y growth & Opportunity Analysis
  • Latin America (Brazil, Mexico, Argentina, Rest of Latin America) Market size, Y-O-Y growth & Opportunity Analysis
  • Europe (U.K., Germany, France, Italy, Spain, Hungary, Belgium, Netherlands & Luxembourg, NORDIC, Poland, Turkey, Russia, Rest of Europe) Market size, Y-O-Y growth & Opportunity Analysis
  • Asia-Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Rest of Asia-Pacific) Market size, Y-O-Y growth & Opportunity Analysis
  • Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa) Market size, Y-O-Y growth & Opportunity Analysis

Market Segmentation

Our in-depth analysis of the global animal arthritis treatment market includes the following segments:

By Treatment

  • Non-Steroidal Anti-Inflammatory Medications (NSAIDs)
  • Opioids
  • Stem Cell Therapy
  • Others

By Distribution Channel

  • Online
  • Offline

Growth Drivers

  • High prevalence of obesity induced arthritis among dogs, growing adoption rate of canines
  • Increasing awareness of the pet-related ailments


  • Increasing regulatory approvals for veterinary drugs and treatments

Top Featured Companies Dominating the Market

  • Boehringer Ingelheim International GmbH
    • Company Overview
    • Business Strategy
    • Key Product Offerings
    • Financial Performance
    • Key Performance Indicators
    • Risk Analysis
    • Recent Development
    • Regional Presence
    • SWOT Analysis
  • Daiichi Sankyo Company, Limited
  • Thorne
  • Nutri-Vet
  • Liquid Health, Inc.
  • American Regent, Inc.
  • Matsun Nutrition


Related Reports

Disclaimer | Privacy Policy | Terms & Conditions

Copyright © 2020 Research Nester. All Rights Reserved